SINGAPORE (Nov 26): Health is wealth — and quite literally so, for Asia’s richest. High-net-worth individuals (HNWIs) in Asia are investing more in health technology companies, says Swiss bank UBS. Even anecdotally, the growing popularity of health-tech investments is visible, notes Patricia Quek, UBS country he ad for Ultra HNW (UHNW) and global family office in Southeast Asia.

Speaking at a briefing during the UBS Healthcare Summit on Oct 19, Quek says: “Last night, over dinner, we [had] investment professionals, private equity fund managers, doctors… and many of them actually choose to invest in biotech, followed by medtech and artificial intelligence. There’s a very strong investment focus on health-tech.”

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook